ArticleFolia microbiologica2026
Postbiotic-mediated antibiofilm activities of newly isolated LAB strains against cariogenic pathogens.
Article in Folia microbiologica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Postbiotics, the metabolites from probiotics, offer a promising approach for controlling oral biofilms through the inhibition of adhesion, degradation of established biofilms, or by exerting antimicrobial effects. This study evaluated the antibiofilm properties of the cell-free supernatants (CFS) of newly isolated Lactiplantibacillus plantarum GS2 and Pediococcus pentosaceus BM1 against cariogenic pathogens Streptococcus mutans and Streptococcus oralis. The antibiofilm activity of concentrated CFS was found to be mediated by heat-stable, protease-resistant bioactive metabolites. pH neutralization of concentrated CFS revealed the effect of non-acidic metabolites on antibiofilm activities. Among the probiotic characteristics, the GS2 strain exhibited higher DPPH scavenging activity (18.76%) and cell-surface hydrophobicity with hexadecane (44.52%), chloroform (63.06%), toluene (38.47%), and benzene (32.27%). Furthermore, both strains exhibited remarkable auto-aggregation and coaggregation properties with oral pathogens. Notably, CFS of GS2 and BM1 exhibited a loss of or weak antimicrobial activity against S. mutans and S. oralis upon pH neutralization, suggesting that the antimicrobial activity is mainly pH-dependent. Interestingly, CFS at their natural and neutralized pH significantly reduced the biomass of pre-formed biofilms (24 h) of S. mutans and S. oralis. In addition, the anti-adherence assay, performed by precoating CFS to the microtiter wells, revealed significant anti-adherence activities (30-40%) against oral pathogens irrespective of their pH. This activity likely indicates the presence of metabolites like biosurfactants that can interfere with surface-pathogen interactions. This study also demonstrated the biocompatibility of neutralized postbiotics in L929 and HGF cell lines, which might be useful for oral applications.
Indexed as
Identifiers
42747688What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.